Greg Martini
Equibles does not estimate personal net worth.
Get an email with a short summary when Kyverna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get KYTX alertsAbout Greg Martini
Greg Martini is recorded as CFO at Kyverna Therapeutics, Inc. (KYTX) since May 18, 2026. Kyverna Therapeutics, Inc. reported in an 8-K filed May 18, 2026 that Greg Martini was appointed Chief Financial Officer, effective May 18, 2026. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kyverna Therapeutics, Inc. includes Warner Biddle (CEO and Board Member), Christi Shaw (Chairman and Board Member), Gregory Martini (CFO and Chief Accounting Officer) and 7 others.
“Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today announced the appointment of Greg Martini as Chief Financial Officer (CFO), effective May 18, 2026.”
Affiliation history
-
Current
2026-05-18–present
Company network
Leadership on record at Kyverna Therapeutics, Inc.
- Warner Biddle CEO, Board Member
- Christi Shaw Chairman, Board Member
- Gregory Martini CFO, Chief Accounting Officer
- Marc Grasso CFO
- Marc Grasso, M.D. CFO
- Mayo Pujols CTO
- Andrew Miller Board Member
- Andrew Miller, Ph.D. Board Member
- Beth Seidenberg Board Member
- Fred E. Cohen Board Member